Search results
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 5 hours agoModerna (NASDAQ: MRNA) is best known for its work in the coronavirus vaccine market. That's why the...
Overwatch 2 April Fools’ Patch Continues A Hilarious Tradition
Kotaku via Yahoo News· 2 months agoAs has become tradition, Blizzard has once again released an absolutely absurd, fully playable...
Can Neosporin in the Nose Help Prevent Viral Infections?
Time via Yahoo News· 2 months agoA tube of Neosporin antibiotic ointment in Illinois on April 14, 2016. Credit - Daniel...
3 Artificial Intelligence (AI) Stocks to Buy This Month: April 2024
Motley Fool via Yahoo Finance· 2 months agoArtificial intelligence stocks are a hot topic on Wall Street. Just remember that a stock's...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 2 months agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
This Dividend Stock Is Up 429% in My Portfolio: 2 Reasons I'd Buy More in a Heartbeat
Motley Fool· 11 months agoBack in March and April of 2020, the world was a very different place. A never-before-seen virus was...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 2 weeks agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 1 month agoInvestors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it...
Why Moderna Stock Is Sinking This Week
Motley Fool via Yahoo Finance· 2 weeks agoShares of Moderna (NASDAQ: MRNA) were sinking 9% lower this week as of Thursday's market close, according to data provided by S&P Global Market...
2 Stocks Down 30% and 27% to Buy and Hold
Motley Fool via Yahoo Finance· 3 months agoNo pair of companies dominated the COVID-19 vaccine market quite like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). Both saw their revenue and earnings...
